Cited by 764Colorectal Cancer Surgical TreatmentsColorectal and Anal CarcinomasGastric Cancer Management and Outcomes

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial

Open access

Aschele, Carlo, Cionini, Luca, Lonardi, Sara, Pinto, Carmine, Cordio, Stefano, Rosati, Gerardo, Artale, Salvatore, Tagliagambe, Angiolo, Ambrosini, Giovanni, Rosetti, Paola, Bonetti, Andrea, Negru, Maria Emanuela, Tronconi, Maria Chiara, Luppi, Gabriele, Silvano, Giovanni, Corsi, Domenico Cristiano, Bochicchio, Anna Maria, Chiaulon, Germana, Gallo, Maurizio, Boni, Luca·2011·Journal of Clinical Oncology

DOI 10.1200/jco.2010.34.4911

Open this paper in CoChat — free account Open PDF

Abstract

Purpose: To investigate oxaliplatin combined with fluorouracil-based chemoradiotherapy as preoperative treatment for locally advanced rectal cancer. Patients and Methods: Seven hundred forty-seven patients with resectable, locally advanced (cT3-4 and/or cN1-2) adenocarcinoma of the mid-low rectum were randomly assigned to receive pelvic radiation (50.4 Gy in 28 daily fractions) and concomitant infused fluorouracil (225 mg/m 2 /d) either alone (arm A, n = 379) or combined with oxaliplatin (60 mg/m 2 weekly × 6; arm B, n = 368). Overall survival is the primary end point. A protocol-planned analysis of response to preoperative treatment is reported here. Results: Grade 3 to 4 adverse events during preoperative treatment were more frequent with oxaliplatin plus fluorouracil and radiation than with radiation and fluorouracil alone (24% v 8% of treated patients; P < .001). In arm B, 83% of the patients treated with oxaliplatin had five or more weekly administrations. Ninety-one percent, compared with 97% in the control arm, received ≥ 45 Gy (P < .001). Ninety-six percent versus 95% of patients underwent surgery with similar rates of abdominoperineal resections (20% v 18%, arm A v arm B). The rate of pathologic complete responses was 16% in both arms (odds ratio = 0.98; 95% CI, 0.66 to 1.44; P = .904). Twenty-six percent versus 29% of patients had pathologically positive lymph nodes (arm A v arm B; P = .447), 46% versus 44% had tumor infiltration beyond the muscularis propria (P = .701), and 7% versus 4% had positive circumferential resection margins (P = .239). Intra-abdominal metastases were found at surgery in 2.9% versus 0.5% of patients (arm A v arm B; P = .014). Conclusion: Adding oxaliplatin to fluorouracil-based preoperative chemoradiotherapy significantly increases toxicity without affecting primary tumor response. Longer follow-up is needed to assess the impact on efficacy end points.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1200/jco.2010.34.4911

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040694 · Cited by 6,050
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Self-citation
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J. M., Hickish, T., Topham, C., Zaninelli, M., Clingan, P. R., Bridgewater, J. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,694
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
Bosset, J.-F., Collette, L., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., Daban, A., Bardet, E., Beny, A., & Ollier, J.-C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060829 · Cited by 2,688
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
Gérard, J.-P., Conroy, T., Bonnetain, F., Bouché, O., Chapet, O., Closon-Dejardin, M.-T., Untereiner, M., Leduc, B., Francois, É., Maurel, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.7629 · Cited by 1,731
Pathological features of rectal cancer after preoperative radiochemotherapy
Dworak, O., Keilholz, L., & Hoffmann, A. (1997) · International Journal of Colorectal Disease · doi:10.1007/s003840050072 · Cited by 1,344
Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy
Trotti, A., Byhardt, R. W., Stetz, J., Gwede, C. K., Corn, B. W., Fu, K. K., Gunderson, L. L., McCormick, B. L., Morris∫, M., Rich, T. A., et al. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00559-3 · Cited by 805
Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2
Gérard, J.-P., Azria, D., Gourgou-Bourgade, S., Martel-Laffay, I., Hennequin, C., Etienne, P.-L., Vendrely, V., François, E., de La Roche, G., Bouché, O., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8376 · Cited by 747
Enhanced Tumorocidal Effect of Chemotherapy With Preoperative Radiotherapy for Rectal Cancer: Preliminary Results—EORTC 22921
Bosset, J.-F., Calais, G., Mineur, L., Maingon, P., Radošević-Jelić, L., Daban, A., Bardet, É., Beny, A., Briffaux, A., & Collette, L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.113 · Cited by 594
Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer
Chau, I., Brown, G. M., Cunningham, D., Tait, D., Wotherspoon, A. C., Norman, A. R., Tebbutt, N. C., Hill, M. E., Ross, P. J., Massey, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4875 · Cited by 472

Show all 29 references

Research works printed but not linked: 1

LH Sobin, CH Wittekind : International Union Against Cancer (UICC) TNM classification of malignant tumours 1997 5th ed New York, NY John Wiley & Sons

Sorted by citations

Items 501–600 of 764

Neoadjuvant Conformal Chemoradiation with Induction Chemotherapy for Rectal Adenocarcinoma. A Prospective Observational Study
Fekete, Z., Muntean, A.-S., Hica, S., Rancea, A., Resiga, L., Csutak, C., Todor, N., & Nagy, V. M. (2014) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.232.zf1 · Cited by 3
Pilot Study of Neoadjuvant Chemoradiotherapy with Three Cycles of 5-Fluorouracil Plus Leucovorin for Treatment of Locally Advanced Rectal Cancer
Lee, S. J., Kang, B. W., Chae, Y. S., Kim, H. J., Park, S., Park, J. S., Choi, G., & Kim, J. G. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4946-9 · Cited by 3
Which way is forward in the treatment of rectal cancer?
Jansen, R. L. H., & Beets, G. L. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.217 · Cited by 3
Effect of Neoadjuvant Chemoradiotherapy on Locally Advanced Rectal Mucinous Adenocarcinoma: A Propensity Score-Matched Study
Sun, Y., Chi, P., Lin, H., Lu, X., Huang, Y., Xu, Z., Huang, S., & Wang, X. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/5715219 · Cited by 3
Effect of time interval between capecitabine intake and radiotherapy on local recurrence-free survival in preoperative chemoradiation for locally advanced rectal cancer
Kim, Y. J., Kim, J. H., Yu, C. S., Kim, T. W., Jang, S. J., Choi, E. K., Kim, J. C., & Choi, W. (2017) · Radiation Oncology Journal · doi:10.3857/roj.2017.00010 · Cited by 3
Session 2: Are we ready for primary chemotherapy in rectal cancer: who, when, why?
Patel, U. B., Cervantes, A. M. R., Fernández-Martos, C., Sclafani, F., Cunningham, D., Nilsson, P. J., & Brown, G. M. (2018) · Colorectal Disease · doi:10.1111/codi.14081 · Cited by 3
Variation in the Thoroughness of Pathologic Assessment and Response Rates of Locally Advanced Rectal Cancers After Chemoradiation
Chow, O. S., Patil, S. N., Keskin, M., Smith, J. J., Widmar, M., Smith, D. D., Avila, K., Shia, J., Chu, P. G., & García‐Aguilar, J. (2019) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04119-x · Cited by 3
The “addition” and “subtraction” of adjuvant chemotherapy for locally advanced colorectal cancer
Chen, X., Lin, Z., & Yu, J. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000473 · Cited by 3
Impact of preoperative chemoradiotherapy using concurrent S-1 and CPT-11 on long-term clinical outcomes in locally advanced rectal cancer
Kimura, K., Beppu, N., Doi, H., Kataoka, K., Yamano, T., Uchino, M., Ikeda, M., Ikeuchi, H., & Tomita, N. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i3.311 · Cited by 3
Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer
Imano, N., Murakami, Y., Kubo, K., Kawahara, D., Takeuchi, Y., Nishibuchi, I., Kimura, T., Kochi, M., Takakura, Y., Shimizu, W., et al. (2020) · Journal of Radiation Research · doi:10.1093/jrr/rraa117 · Cited by 3
Four steps in the evolution of rectal cancer managements through 40 years of clinical practice: Pioneering, standardization, challenges and personalization
Valentini, V., Alfieri, S., Coco, C., D’Ugo, D., Crucitti, A., Pacelli, F., Persiani, R., Sofo, L., Picciocchi, A., Doglietto, G. B., et al. (2024) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2024.110190 · Cited by 3
The multidisciplinary management of locally advanced rectal cancer
Felice, F. D., Miccini, M., Botticelli, A., Roberto, M., & Petrucciani, N. (2024) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2024.2349137 · Cited by 3
Optimal Sequencing of Neoadjuvant Therapies (NAT) in Rectal Cancer: Upfront Chemotherapy vs. Upfront Chemoradiation
Fernández-Martos, C., Fadrique, A. G., & Glynne‐Jones, R. (2017) · Current Colorectal Cancer Reports · doi:10.1007/s11888-017-0358-5 · Cited by 3
Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma
de la Pinta, C., Martín, M., Hervas, A., Perna, L. C., Fernández-Lizarbe, E., López, F., Duque‐Santana, V., & Sancho, S. (2020) · Journal of Coloproctology · doi:10.1016/j.jcol.2019.10.013 · Cited by 3
Randomized Trials and New Directions in Gastrointestinal Cancer
Chang, D. T., Brunner, T. B., Cheng, J. C., Liauw, S. L., Meyer, J. J., & Wo, J. Y.-L. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.10.015 · Cited by 3
Oxaliplatin for colorectal cancer: recent evidence from clinical trials
Stein, A., Quidde, J., & Arnold, D. (2013) · Colorectal Cancer · doi:10.2217/crc.13.16 · Cited by 3
Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis
Nakagawa, R., Inoue, Y., Ohki, T., Kaneko, Y., Maeda, F., & Yamamoto, M. (2017) · World Journal of Surgical Oncology · doi:10.1186/s12957-017-1177-5 · Cited by 3
Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-up
Gambacorta, M. A., Paoli, A. D., Lupattelli, M., Chiloiro, G., Solazzo, A., Barbaro, B., Alfieri, S., Vecchio, F. M., Lenkowicz, J., Navarria, F., et al. (2018) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2018.02.003 · Cited by 3
Rectal Cancer
Minsky, B. D., Rödel, C. M., & Valentini, V. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24098-7.00051-4 · Cited by 3
Strahlentherapie des Rektumkarzinoms
Wolf, M. C., Zehentmayr, F., & Belka, C. (2012) · Der Radiologe · doi:10.1007/s00117-011-2286-8 · Cited by 3
Factors Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: The Experience of a Single Institution with 269 Patients (STONE-01)
Fiore, M., Trecca, P., Trodella, L. E., Coppola, R., Caricato, M., Caputo, D. D., Coppola, A., Petrianni, G. M., D’Ercole, G., Ippolito, E., et al. (2021) · Cancers · doi:10.3390/cancers13236074 · Cited by 3
Adding Consolidation Capecitabine to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Propensity-Matched Comparative Study
Fang, Y., Sheng, C., Ding, F., Zhao, W., Guan, G., & Liu, X. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2021.770767 · Cited by 3
Rectal and Colon Cancer: Radiation Therapy Planning
Kamran, S. C., Mamon, H. J., & Wo, J. Y.-L. (2017) · Springer eBooks · doi:10.1007/978-3-319-43115-4_14 · Cited by 3
Fragility Index analysis for robustness of evidence in Randomized Controlled Trials in National Comprehensive Cancer Network ( NCCN) guidelines for rectal cancer
Horesh, N., Dourado, J., Rogers, P. D., Aeschbacher, P., Garoufalia, Z., Gefen, R., Salama, E., Emile, S. H., & Wexner, S. D. (2025) · International Journal of Cancer · doi:10.1002/ijc.35521 · Cited by 2
Optimal choice of different neoadjuvant chemoradiotherapies for locally advanced rectal cancer: systematic review and network meta-analysis
Liu, L., Yao, G., Yang, J., Miao, Y., Ba, Y., & Wang, X. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10279-x · Cited by 2
Short‐Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
Zhang, R., Wang, F., Jiang, X., Wang, H., Zhang, W., Zeng, Z., Gao, Y., Wu, X., Chen, G., Li, L., et al. (2025) · MedComm · doi:10.1002/mco2.70222 · Cited by 2
Prognostic discrepancies between surgery-first and neoadjuvant-treated resected pancreatic cancer in the same pathological stage
Yamada, S., Oshima, K., Nomoto, K., SANADA, S., Oshima, Y., Ito, M., & Nakao, A. (2025) · Surgery Today · doi:10.1007/s00595-025-03163-2 · Cited by 2
SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2025)
Aguilera, M. J. S., Gaspà, F. L., González‐Flores, E., Mirón, M. L. L., Mozo, J. L. M., Martínez, M. D. C. R., Tocino, R. V., Alonso-Orduña, V., Asensio, E., & García, R. V. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-04140-4 · Cited by 2
Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer
Heras, M. D. L., Arias, F., del Moral-Ávila, R., Gómez‐Millán, J., Jimenez, E. T., Wals-Zurita, A., Tisaire, J. L., & Alcántara, M. P. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0915-y · Cited by 2
Management of distal rectal cancer: results from a national survey
Melotti, G. L., Antoni, E. D., Habr‐Gama, A., & Minicozzi, A. (2013) · Updates in Surgery · doi:10.1007/s13304-012-0192-x · Cited by 2
Strahlentherapieassoziierte Morbidität und Mortalität in der Rektumchirurgie
Kulu, Y., Büchler, M. W., & Ulrich, A. B. (2013) · Der Chirurg · doi:10.1007/s00104-013-2515-y · Cited by 2
Rectal Cancer: Watch and Wait
Chang, G. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-25970-3_30 · Cited by 2
The Role of Adjuvant Treatment in Resected T3N0 Rectal Cancer
Gbolahan, O. B., & O’Neil, B. H. (2016) · Current Colorectal Cancer Reports · doi:10.1007/s11888-016-0340-7 · Cited by 2
Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience
Caputo, F., Santini, C., Gardini, A. C., Cerma, K., Bardasi, C., Garajová, I., Lattanzi, E., Passardi, A., Rapposelli, I. G., Spallanzani, A., et al. (2022) · Future Oncology · doi:10.2217/fon-2021-1646 · Cited by 2
Self-citation
Imagerie par résonance magnétique dans le bilan préthérapeutique des cancers du rectum
Protin-Catteau, L., Amara-Slimani, N., Rousset, P., Fornés, P., Amzallag-Bellenger, É., Deguelte-Lardière, S., Véron, S., & Hoeffel, C. C. (2013) · Cited by 2
Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal Cancer
Nishimura, J., Hasegawa, J., Noura, S., Ikeda, K., Yasui, M., Komori, T., Tsujie, M., Yasumasa, K., Shingai, T., Uemura, M., et al. (2020) · Journal of the Anus Rectum and Colon · doi:10.23922/jarc.2019-042 · Cited by 3
Treatment in locally advanced rectal cancer: a machine learning bibliometric analysis
Felice, F. D., Crocetti, D., Petrucciani, N., Belgioia, L., Sapienza, P., Bulzonetti, N., Marampon, F., Musio, D., & Tombolini, V. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211042170 · Cited by 2
Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer
Li, Z., Wang, X., Li, M., Liu, X.-J., Ye, Z., Song, B., Yuan, F., Yuan, Y., Xia, C., Zhang, X., et al. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i19.2387 · Cited by 2
Total neoadjuvant therapy in rectal cancer
Piringer, G., & de Vries, A. (2022) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-022-00854-1 · Cited by 2
Stratégies de préservation d’organe dans le traitement des cancers du rectum
Vendrely, V., Denost, Q., Amestoy, F., Célérier, B., Smith, D. M., Rullier, A., & Rullier, É. (2015) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2015.05.009 · Cited by 2
Chimioradiothérapie préopératoire du cancer du rectum : expérience d’un centre
Lescut, N., Lépinoy, A., Schipman, B., Cerda, T., Guimas, V., Bednarek, C., & Bosset, J.-F. (2015) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2014.11.011 · Cited by 2
Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experience
Beveridge, R. D., Aparicio, J., Tormo, A., Estevan, R., Artés, J., Giménez, A., Segura, Á., Roldán, S., Palasí, R., & Ramos, D. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0826-y · Cited by 2
Oxaliplatin-Based Adjuvant Chemotherapy without Radiotherapy Can Improve the Survival of Locally-Advanced Rectal Cancer
Li, J., Liu, Y., Wang, J., Gao, Y., Hu, Y., He, J., Yu, X., Hu, H., Yuan, Y., Zhang, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107872 · Cited by 2
Intensity-modulated radiation therapy for patients with rectal cancer
Vuong, T., Garant, A., & Gallant, F. (2014) · Colorectal Cancer · doi:10.2217/crc.14.20 · Cited by 2
Eastern Canadian Colorectal Cancer Consensus Conference 2013: Emerging Therapies in the Treatment of Pancreatic, Rectal, and Colorectal Cancers
Valentin, T. D., Asmis, T. R., Asselah, J., Aubin, F., Aucoin, N., Berry, S., Biagi, J. J., Booth, C. M., Burkes, R. L., Coburn, N. G., et al. (2016) · Current Oncology · doi:10.3747/co.23.2897 · Cited by 2
Is There a Best Radiosensitizing Agent in the Treatment of Locally Advanced Rectal Cancer?
Coveler, A. L., Richard, P., Apisarnthanarax, S., & Chiorean, E. G. (2016) · Current Colorectal Cancer Reports · doi:10.1007/s11888-016-0324-7 · Cited by 2
PREOPERATIVE SHORT-COURSE RADIOTHERAPY COMBINED WITH CHEMOTHERAPY, LOCAL HYPERTHERMIA AND DELAYED SURGERY IN TREATMENT OF RECTAL CANCER: PHASE II TRIAL
Расулов, А. О., Гордеев, С. С., Ivanov, V. A., Геннадьевич, М. А., Barsukov, Y. А., Baychorov, A. B., Si, T., & Kozak, E. (2017) · Surgery and Oncology · doi:10.17650/2220-3478-2016-6-4-24-30 · Cited by 2
The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer
Rühlmann, F., Nietert, M. M., Sprenger, T., Wolff, H. A., Homayounfar, K., Middel, P., Bohnenberger, H., Beißbarth, T., Ghadimi, Β. M., Liersch, T., et al. (2017) · Journal of Cancer · doi:10.7150/jca.16980 · Cited by 2
Maximizing Neoadjuvant Treatment Response and Watch and Wait
Chow, O. S., & García‐Aguilar, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-16384-0_18 · Cited by 2
Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt
Formica, V., Benassi, M., Blanco, G. D. V., Doldo, E., Martano, L., Portarena, I., Nardecchia, A., Lucchetti, J., Morelli, C., Giudice, E., et al. (2018) · Medical Oncology · doi:10.1007/s12032-018-1141-4 · Cited by 2
Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: long-term oncologic outcomes
Park, S. W., Kim, J. S., Kim, J., & Lee, K. H. (2018) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2018.94.6.306 · Cited by 2
Reevaluation of Preoperative Chemoradiotherapy for Clinical T3 Lower Rectal Cancer: A Multicenter Collaborative Retrospective Clinical Study
TAKEDA, M., Kawahara, H., Ogawa, M., Suwa, K., Eto, K., & Yanaga, K. K. (2019) · Anticancer Research · doi:10.21873/anticanres.13438 · Cited by 2
Treatment of Rectal Cancer
Artaç, M., El‐Rayes, B. F., Yalçın, Ş., & Philip, P. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-18890-0_9 · Cited by 2
Tolerability of Oxaliplatin-based Neoadjuvant Chemoradiotherapy in Elderly Locally Advanced Rectal Cancer Patients: A Case-control Study of a Real-life Experience
Felice, F. D., Siniscalchi, B., Bulzonetti, N., Caiazzo, R., Musio, D., & Tombolini, V. (2019) · Anticancer Research · doi:10.21873/anticanres.13917 · Cited by 2
The Older Adults With Rectal Cancer—Does Age Matter?
Shulman, K., Musallam, S., Epelbaum, R., Haim, N., Ben-Yosef, R., & Kaidar‐Person, O. (2020) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000767 · Cited by 2
Neoadjuvant therapy for locally advanced rectal cancer
Fedyanin, M. Y., & Tryakin, A. A. (2022) · Surgery and Oncology · doi:10.17650/2686-9594-2022-12-2-36-45 · Cited by 2
Előrehaladott végbéldaganatok neoadjuváns (preoperatív) kemoradioterápiája
Kóder, G., Olasz, J., Tóth, L. F., András, C., Bubán, T., Palatka, K., Karányi, Z., Tóth, D., Damjanovich, L., & Tanyi, M. (2022) · Orvosi Hetilap · doi:10.1556/650.2022.32497 · Cited by 2
Predictors of Definitive Treatment Interruptions of Long-Course Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Sapienza, L. G., Raychaudhuri, S., Nahlawi, S. K., Ozeir, S., & Abu-Isa, E. I. (2022) · Cureus · doi:10.7759/cureus.30159 · Cited by 2
Long-term results of a phase 2 study of neoadjuvant chemotherapy with molecularly targeted agents for locally advanced rectal cancer
Aoyama, R., Hida, K., Hasegawa, S., Yamaguchi, T., Manaka, D., Kato, S., Yamada, M., Yamanokuchi, S., Kyogoku, T., Kanazawa, A., et al. (2023) · International Journal of Clinical Oncology · doi:10.1007/s10147-023-02291-4 · Cited by 2
Response to Neoadjuvant Chemoradiotherapy as a Predictor of Long-Term Survival in Patients with Locally Advanced Rectosigmoid Junction Cancer: An Analysis Based On SEER Database
Shen, Q., Liu, D., & Liu, S. (2023) · Iranian Journal of Public Health · doi:10.18502/ijph.v52i9.13575 · Cited by 2
Six Cases Treated with a New Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Colorectal Cancer
Ota, G., & Ishibashi, T. (2015) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.76.1989 · Cited by 2
Radiation Therapy: The North American Approach
Lanning, R. M., & Goodman, K. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-98902-0_21 · Cited by 2
[Detection of preoperative chemoradiotherapy sensitivity molecular characteristics of rectal cancer by transcriptome second generation sequencing].
Zhang, W., Ye, Y. J., Ren, X., Huang, J., & Shen, Z. (2019) · PubMed Central · doi:10.19723/j.issn.1671-167x.2019.03.025 · Cited by 2
"Watch and Wait" for complete clinical response after neoadjuvant chemoradiotherapy for rectal cancer
Peacock, O., & Chang, G. J. (2020) · Minerva Chirurgica · doi:10.23736/s0026-4733.19.08184-7 · Cited by 2
Neoadjuvant chemotherapy with or without oxaliplatin after short-course radiotherapy in high-risk rectal cancer: A subgroup analysis from a prospective study
Kosakowska, E., Pietrzak, L., Michalski, W., Kępka, L., Polkowski, W. P., Jankiewicz, M., Ciseł, B., Kryński, J., Zwolinski, J., Wyrwicz, L. S., et al. (2020) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2020.08.002 · Cited by 3
Perioperative Therapie des Rektumkarzinoms: Was ist Standard? Wird sich der Standard ändern?
Hofheinz, R., & Rödel, C. M. (2011) · Viszeralmedizin · doi:10.1159/000335219 · Cited by 2
Tumor-Based Screening for Hereditary Nonpolyposis Colorectal Cancer: Does Age-Based Selection Optimize Yield?
Lynch, P. M. (2013) · Journal of Oncology Practice · doi:10.1200/jop.2012.000786 · Cited by 2
Reply to Letter
Petrelli, F., & Barni, S. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000772 · Cited by 2
Inklusion von Oxaliplatin in die multimodale Behandlung des lokal fortgeschrittenen Rektumkarzinoms
Rödel, C. M., & Fokas, E. (2016) · Strahlentherapie und Onkologie · doi:10.1007/s00066-016-1090-9 · Cited by 2
What Is the Prognostic Value of the (Y)pN Status After Chemoradiotherapy in Rectal Cancer?
Glynne‐Jones, R., Tan, D. S. P., & West, N. P. (2018) · Springer eBooks · doi:10.1007/978-3-319-43217-5_64 · Cited by 1
Watch and Wait in Rectal Cancer Patients with Clinical Complete Response to Neoadjuvant Therapy: The American Viewpoint
Quezada-Díaz, F., Sammour, T., Smith, J. J., & You, Y. N. (2019) · Springer eBooks · doi:10.1007/978-3-319-98902-0_11 · Cited by 1
The efficacy and safety of different radiotherapy doses in neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Zhang, Y., Jiang, P., Zhu, H. L., Dong, B., Zhai, H., & Chen, Z. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-296 · Cited by 1
Executive Summary of the American Radium Society on Appropriate Use Criteria for Nonoperative Management of Rectal Adenocarcinoma: Systematic Review and Guidelines
Anker, C. J., Tchelebi, L. T., Selfridge, J. E., Jabbour, S. K., Akselrod, D. G., Cataldo, P. A., Abood, G. J., Berlin, J. D., Hallemeier, C. L., Jethwa, K. R., et al. (2024) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2024.05.019 · Cited by 2
Molecular biomarkers for predicting complete response to preoperative chemoradiation in people with locally advanced rectal cancer
Lacavalerie, P. D., Lord, S. J., Morgan, M. J., Caldon, C. E., & Kohonen‐Corish, M. R. J. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014718 · Cited by 1
“Add More Arrows to Your Quiver”: The Role of Adding Another Chemotherapy Drug to Fluoropyrimidine and Long Term Radiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis
Giuliani, J., Tebano, U., Mandarà, M., Franceschetto, A., Giorgi, C., Missiroli, S., Gabbani, M., Napoli, G., Luca, N., Mangiola, D., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020345 · Cited by 1
Organ Function Preservation in Locally Advanced Low Rectal Cancer Through Total Neoadjuvant Therapy: A Case Report and Literature Review
Liu, F., Li, Y., Zhao, Y., Li, G., & He, X. (2025) · Cancer Management and Research · doi:10.2147/cmar.s499531 · Cited by 1
Tumor regression pattern may impact the prognosis of rectal cancer patients with tumor regression grade 1 after neoadjuvant chemoradiotherapy
Tang, Y., Zhou, J., Gu, X.-F., Yang, L.-J., Li, D., Duan, J.-Y., Jiang, D., & Wang, X. (2023) · Gastroenterology report · doi:10.1093/gastro/goae050 · Cited by 1
Controversies and Perspectives in the Current Management of Patients with Locally Advanced Rectal Cancer—A Systematic Review
Stefan, R. E., Bîrlă, R., Gheorghe, M., Dinu, D., Hoara, P. A., Ciuc, D. M., Dinca, V.-G., & Constantinoiu, S. M. (2025) · Life · doi:10.3390/life15071011 · Cited by 4
Neoadjuvant Therapy for Organ Preservation in Locally Advanced Rectal Cancer: A Review
Qiu, L., & Li, J. (2025) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s518959 · Cited by 1
Current State-of-the-Science Adjuvant and Neoadjuvant Therapy in Surgically Resected Colorectal Cancer
Şahin, İ. H., & Garrett, C. R. (2014) · InTech eBooks · doi:10.5772/57481 · Cited by 1
What more do we want from neoadjuvant treatment strategies in rectal cancer?
Habr‐Gama, A., Fernandez, L. M., & Perez, R. O. (2015) · Colorectal Cancer · doi:10.2217/crc.15.5 · Cited by 1
A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasis
Ohue, M., Hamaguchi, T., Ito, Y., Sakai, D., Noura, S., Kinugasa, Y., Fujita, S., Shimada, Y., Saito, N., & Moriya, Y. (2014) · International Journal of Clinical Oncology · doi:10.1007/s10147-014-0705-3 · Cited by 1
Chimiothérapie du cancer du rectum
Michel, P., & Fiore, F. D. (2011) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2011.06.002 · Cited by 1
Future directions in surgery for colorectal cancer: the evolving role of transanal endoscopic surgery
Emhoff, I. A., Lee, G. C., & Sylla, P. A. (2014) · Colorectal Cancer · doi:10.2217/crc.14.8 · Cited by 1
The outcome of 5-fluorouracil chemotherapy after the completion of neoadjuvant chemoradiotherapy, administered until 2 weeks before rectal cancer resection
Chang, P.-K., Chiang, M., Jao, S., Wu, C., Lee, C., Lee, T., & Hsiao, C.-W. (2015) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2015.05.007 · Cited by 1
Have we put the cart before the horse? Reordering treatments for rectal cancer
Perez, K. J. (2014) · Colorectal Cancer · doi:10.2217/crc.14.33 · Cited by 1
Future of therapy for rectal cancer.
Minsky, B. D. (2013) · PubMed · doi:10.3978/j.issn.2304-3865.2013.03.01 · Cited by 1
Perioperative Therapie des lokal fortgeschrittenen Rektumkarzinoms
Hofheinz, R., Liersch, T., & Rödel, C. M. (2013) · coloproctology · doi:10.1007/s00053-013-0369-x · Cited by 1
The best timing for administering systemic chemotherapy in patients with locally advanced rectal cancer.
Shimodaira, Y., Harada, K., Lin, Q. D., & Ajani, J. A. (2016) · PubMed Central · doi:10.3978/j.issn.2305-5839.2016.01.08 · Cited by 1
The Combination of Neoadjuvant Chemoradiotherapy and Epidermal Growth Factor Receptor Inhibitors in the Treatment of Rectal Adenocarcinoma
Richter, I., Dvořák, J., & Bartoš, J. (2014) · Klinicka onkologie · doi:10.14735/amko2014166 · Cited by 1
Neoadjuvant FOLFOX Therapy for Locally Advanced Rectal Cancer
Koike, J., Funahashi, K., Shiokawa, H., Ushigome, M., Shirasaka, K., Kagami, S., Suzuki, T., Matsuda, S., Shimada, H., & Kaneko, H. (2012) · Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) · doi:10.4030/jjcs.37.691 · Cited by 1
Gastrointestinal Cancers—Changing the Standard for Rectal Cancer and Establishing a New Standard for Liver Tumors
Apisarnthanarax, S., Cheng, J. C., Jabbour, S. K., Liauw, S. L., Murphy, J. D., & Chang, D. T. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.02.024 · Cited by 1
Which rectal cancers are locally advanced?
Glimelius, B. L. G. (2012) · PubMed · Cited by 1
Importance of neoadjuvant treatment in management of locally advanced rectal cancer
Vasić, L. (2018) · Биомедицинска истраживања · doi:10.7251/bii1801083v · Cited by 1
Capecitabine and Oxaliplatin versus 5-Fluorouracil in the Neoadjuvant Chemoradiation for Patients with Locally Advanced Rectal Carcinoma: A Comparative Study
Rayan, A., Hasan, H. A., Zahran, A. M., Soliman, A. S. A., & Rezk, K. (2018) · Journal of Cancer Therapy · doi:10.4236/jct.2018.910063 · Cited by 1
Novel approaches to treatment of locally advanced rectal cancer
Качмазов, А. А., Болотина, Л. В., Kornietskaya, A. L., Karagodina, Y. B., Droshneva, I. V., & Феденко, А. А. (2020) · Surgery and Oncology · doi:10.17650/2686-9594-2020-10-3-4-73-83 · Cited by 1
Cancer of the Rectum
Sigurdson, E. R., Benson, A. B., & Minsky, B. D. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00078-3 · Cited by 1
The frequency of achieving complete therapeutic pathomorphosis when using sandwich-therapy for locally advanced rectal cancer
Анискин, А. А., Kuzmichev, D. V., Mamedli, Z. Z., Гордеев, С. С., Polynovskiy, A. V., & Madyarov, Z. M. (2021) · Clinical and Experimental Surgery Petrovsky journal · doi:10.33029/2308-1198-2021-9-1-45-54 · Cited by 1
Three-year outcomes of sandwich therapy in patients with locally advanced cancer of the middle and lower rectum
Анискин, А. А., Kuzmichev, D. V., Mamedli, Z. Z., & Polynovskiy, A. V. (2021) · Surgery and Oncology · doi:10.17650/2686-9594-2021-11-2-29-35 · Cited by 1
Phase II Study of Preoperative Chemoradiotherapy With S-1 Plus Oxaliplatin for Locally Advanced Rectal Cancer (PerSeUS-RC01)
Matsuhashi, N., Takahashi, T., Tanaka, C., Yawata, K., Yamada, M., IWATA, Y., Kiyama, S., Mizutani, C., Tajima, J. Y., Ishihara, T., et al. (2021) · Anticancer Research · doi:10.21873/anticanres.15445 · Cited by 1

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
Rödel, C. M., Graeven, U., Fietkau, R., Hohenberger, W., Hothorn, T., Arnold, D., Hofheinz, R., Ghadimi, M. B., Wolff, H. A., Lang-Welzenbach, M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00159-x · Cited by 736
Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial
Aschele, C., Pinto, C., Cordio, S., Rosati, G., Tagliagambe, A., Artale, S., Rosetti, P., Lonardi, S., Boni, L., & Cionini, L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.18s.cra4008 · Cited by 13
Self-citation
Final results of STAR-01: A randomized phase III trial comparing preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer.
Aschele, C., Lonardi, S., Cionini, L., Pinto, C., Cordio, S. S., Rosati, G., Bianchi, A. S., Tagliagambe, A., Frisinghelli, M., Zagonel, V., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.3521 · Cited by 42
Self-citation
Preoperative concomitant chemoradiotherapy with oxaliplatin and 5-fluorouracil in locally advanced rectal carcinoma
Djellali, L., Larbaoui, B., Boukerche, A., Ghazi, S. H., Chaiba, I., Meziane, N., Yekrou, D., & Youcef, D. F. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.e15108 · Cited by 1
A phase II study of oxaliplatin with 5-FU/folinic acid and concomitant radiotherapy as a preoperative treatment in patients with locally advanced rectal cancer.
Chitapanarux, I., Chitapanarux, T., Tharavichitkul, E., Mayurasakorn, S., Siriwittayakorn, P., Yamada, S., & Lorvidhaya, V. (2011) · PubMed Central · doi:10.2349/biij.7.4.e25 · Cited by 5

See all

Authors: Aschele, C., Cionini, L., Lonardi, S., Pinto, C., Cordio, S., Rosati, G., Artale, S., Tagliagambe, A., Ambrosini, G., Rosetti, P., Bonetti, A., Negru, M. E., Tronconi, M. C., Luppi, G., Silvano, G., Corsi, D. C., Bochicchio, A. M., Chiaulon, G., Gallo, M., & Boni, L.
Affiliations: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
ORCID: Aschele, Carlo
Lonardi, Sara
Pinto, Carmine
Rosati, Gerardo
Bonetti, Andrea
Tronconi, Maria Chiara
Luppi, Gabriele
Silvano, Giovanni
Corsi, Domenico Cristiano
Bochicchio, Anna Maria
Boni, Luca
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2011-07-10
Volume: 29
Issue: 20
Pages: 2773-2780
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.2010.34.4911
OpenAlex: W2123712900
Cited by: 763
References: 29
Citations by year: 2026: 8 · 2025: 23 · 2024: 24 · 2023: 21 · 2022: 37 · 2021: 42 · 2020: 60 · 2019: 60 · 2018: 59 · 2017: 72 · 2016: 61 · 2015: 83 · 2014: 62 · 2013: 64 · 2012: 69
FWCI: 33.33
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
Funders: Amgen
Sanofi
Topics: Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Health Sciences › Medicine › Surgery › Colorectal and Anal Carcinomas
Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
Keywords: locally advanced rectal cancer, neoadjuvant chemoradiotherapy, oxaliplatin, 5-fluorouracil, pelvic radiotherapy, pathological complete response, circumferential resection margin, lymph node metastasis, treatment toxicity, abdominoperineal resection, overall survival
MeSH terms: Oxaliplatin, Adenocarcinoma, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Female, Fluorouracil, Humans, Italy, Male, Middle Aged, Organoplatinum Compounds, Rectal Neoplasms, Survival Analysis, Dose Fractionation, Radiation, Neoadjuvant Therapy, Medication Adherence, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks